IP Library Granted Patent US 11,672,976
Granted Patent B2
US 11,672,976 · App. 17/065,687 · Granted Jun 13, 2023

Lead for an active implantable medical device with decoy

Inventor: Peter Scott Vallack Single (Artarmon, AU)
Assignee: Saluda Medical Pty Limited
A61N1/086A61N1/3605A61N1/0534A61N1/0551
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,976
App. No.
17/065,687
Granted
Jun 13, 2023
Kind
B2
Abstract

A lead ( 1 ) for an active implantable medical device comprising: an elongated, biocompatible, electrically non-conductive body ( 3 ); a plurality of electrically conductive filaments ( 5 ) inside the elongated body ( 3 ) to electrically connect electrical connectors ( 6 ) to corresponding electrodes ( 8 ); and at least one elongated decoy conductor ( 10 ) inside the elongated body ( 3 ) to electromagnetically couple with the plurality of electrically conductive filaments ( 5 ), wherein the at least one decoy conductor ( 10 ) has a higher electrical resistance than the plurality of electrical conductive filaments ( 5 ) to dissipate energy from currents induced by radio frequencies.

Claims (22)

1. A lead for an active implantable medical device comprising:

an elongated, biocompatible, electrically non-conductive body;

a plurality of electrically conductive filaments inside the elongated body to electrically connect electrical connectors to corresponding electrodes; and

at least one elongated decoy conductor inside the elongated body to electromagnetically couple with the plurality of electrically conductive filaments,

wherein the at least one elongated decoy conductor has a higher electrical resistance than the plurality of electrical conductive filaments to dissipate energy from currents induced by radio frequencies, and

wherein the elongated body includes multiple lumens, wherein the electrically conductive filaments are located in a subset of the multiple lumens that are separate from other lumens, in the multiple lumens, that receive the at least one elongated decoy conductor.

2. A lead according to claim 1 , wherein the at least one elongated decoy conductor is located substantially parallel to the plurality of electrically conductive filaments.

3. A lead according to claim 1 , wherein the at least one elongated decoy conductor is electrically insulated from the plurality of electrically conductive filaments, connectors and electrodes by the elongated body.

4. A lead according to claim 1 , wherein the multiple lumens are arranged as a set of planetary lumens around a core of the elongated body.

5. A lead according to claim 1 , wherein the multiple lumens include a dozen lumens.

6. A lead according to claims 1 , wherein the at least one elongated decoy conductor includes two or more elongated decoy conductors evenly spaced from each other in the multiple lumens.

7. A lead according to claim 1 , wherein the at least one elongated decoy conductor includes four elongated decoy conductors evenly spaced from each other in the multiple lumens.

8. A lead according to claim 1 , wherein the at least one elongated decoy conductor is shorter than each of the plurality of electrically conductive filaments.

9. A lead according to claim 1 , wherein a conductor length of the at least one elongated decoy conductor is approximately 90% of a length of the lead.

10. A lead according to claim 1 , wherein a conductor length of the at least one elongated decoy conductor is matched with an expected wavelength of a radio frequency (RF) field from an MRI.

11. A lead according to claim 10 , wherein a conductor length includes odd integer multiples of half the expected wavelength of the RF field from the MRI.

12. A lead according to claim 1 , wherein a conductor length of the at least one elongated decoy conductor is in the range of 500 mm to 900 mm.

13. A lead according to claim 1 , wherein a conductor length of the at least one elongated decoy conductor is in the range of 10% to 90% of the length of the longest electrically conductive filament.

14. A lead according to claim 1 , wherein the at least one elongated decoy conductor has a length specific resistance of 300 to 1000 Ohms/metre.

15. A lead according to claim 1 , wherein the at least one elongated decoy conductor comprises: nichrome and/or carbon fibre.

16. A lead according to claim 1 , wherein each of the at least one elongated decoy conductors has a diameter of 70 μm to 200 μm.

17. A lead according to claim 1 , wherein the elongated, biocompatible, electrically non-conductive body comprises thermoplastic polyurethane.

Assignments (2)
SECURITY INTEREST Recorded Mar 14, 2025
From: SALUDA MEDICAL PTY LTD
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070518/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2020
From: SINGLE, PETER SCOTT VALLACK
To: SALUDA MEDICAL PTY LIMITED
Reel/Frame 054006/0689 →
Priority Claims (1)
AU 2019903815 · Oct 10, 2019 · national
Continuity (1)
Related Publication 20210106818A1 · Apr 15, 2021